
Orthobond: A biotech firm enhancing safety and performance of implantable medical devices.
Orthobond, founded with a mission to enhance the safety and performance of implantable medical devices, is a biotechnology company specializing in antimicrobial technology. The company has developed proprietary antimicrobial nanosurfaces designed to prevent contamination and infection, thereby improving patient outcomes. Orthobond's primary market focus is on the medical device industry, where their innovative solutions aim to set new standards in device safety and efficacy.
Key figures associated with Orthobond include leading experts in biotechnology and materials science, although specific names are not provided. The company has garnered attention for its groundbreaking antimicrobial nanosurfaces, which have broad applications beyond just medical devices. Orthobond's impact is evident in its contribution to reducing infection rates and enhancing the overall safety of implantable devices, positioning it as a significant player in the biotech and medical device sectors.

RevOrtho
revortho.com
New Ortho Polymers

NuOrtho Surgical

OrthoFundamentals

Novum Medical

Bone Biologics

OsteoCentric Technologies
osteocentric.com

OsteoNovus
osteonovus.com

Orthofix
orthofix.com

ForCast Orthopedics
forcastortho.com

Ortho-tag
ortho-tag.com

Orion Medical

Garwood Medical Devices

BioSurfaces
biosurfaces.us

MX Orthopedics
Companies similar to Orthobond include RevOrtho, New Ortho Polymers, NuOrtho Surgical and OrthoFundamentals.
Orthobond was founded in 2004.
Orthobond's headquarters is located in Monmouth Junction, NJ, US.
Orthobond's most recent funding round was for $2.1M (USD) in October 2011.
As of Oct 21, 2011, Orthobond has raised a total of $2.1M (USD).
Orthobond has 17 employees as of Feb 5, 2024.